Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Disc Medicine | 2025 | Post-IPO Equity | Undisclosed | Watertown |
| Tricida | 2022 | Post-IPO Debt | Undisclosed | Menlo Park |
| Urban Company | 2026 | Post Ipo Secondary | $68.3M | Gurgaon |
| Quince | 2026 | Series E | $500.0M | San Francisco |
| Span | 2026 | Corporate Round | $75.0M | San Francisco |
| 2026 | Post Ipo Debt | $1.0B | San Francisco | |
| Encord | 2026 | Series C | $60.0M | San Francisco |
| Angitia Biopharmaceuticals | 2026 | Series D | $130.0M | Westlake Village |
| Forerunner | 2026 | Series B | $26.3M | San Francisco |
| Juspay | 2026 | Series D | $50.0M | Kormangala |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Disc Medicine | Post-IPO Equity | Undisclosed | Watertown, United States |
| 102 | Tricida | Post-IPO Debt | Undisclosed | Menlo Park, United States |
| 103 | Urban Company | Post Ipo Secondary | $68.3M | Gurgaon, India |
| 104 | Quince | Series E | $500.0M | San Francisco, United States |
| 105 | Span | Corporate Round | $75.0M | San Francisco, United States |
| 106 | Post Ipo Debt | $1.0B | San Francisco, United States | |
| 107 | Encord | Series C | $60.0M | San Francisco, United States |
| 108 | Angitia Biopharmaceuticals | Series D | $130.0M | Westlake Village, United States |
| 109 | Forerunner | Series B | $26.3M | San Francisco, United States |
| 110 | Juspay | Series D | $50.0M | Kormangala, India |
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Urban Company provides home cleaning, maintenance, and beauty treatment services conveniently delivered to the doorstep.
Quince is an e-commerce company that offers apparel, accessories, home goods, and personal care products through an online platform.
Span develops residential energy storage devices that provide renewable electricity and charging services for electric vehicles.
Pinterest is a visual bookmarking tool for saving and discovering creative ideas.
Train and run AI on the right data
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Forerunner is an AI-powered geospatial platform that assists governments in updating their operations and enhancing community resilience.
Juspay is an enterprise payment solutions provider, helping merchants and banks streamline their payment processes globally.
Dave is a banking app that offers customers banking, financial insights, overdraft protection, and building credit products.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Crisp ingests and delivers daily, actionable retail data from different sources, providing brands with visibility into inventory and sales.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Flex is a financial technology company that offers an end-to-end finance platform that integrates business and personal finance management.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
SoFi is a finance company that offers a range of lending and wealth management services.
Lumafield develops industrial computed tomography (CT) solutions for non-destructive testing and inspection for engineers.
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Keychain is an AI-powered platform for CPG manufacturing companies that enables seamless product creation and supplier connections.
Agentic AI platform that unlocks intelligence from silos of contracts and financial data, driving prioritized outcomes at speed and scale.
SKIMS provides a wide-ranging line of underwear, loungewear, and shapewear designed to deliver solutions for every body.
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Wellington Management has invested in 228 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Software. The firm invests across 54 different industry categories.
Among tracked funding rounds, SoFi received $1.5B in a Post Ipo Equity round. Wellington Management's total known invested capital is $36.2B.
Wellington Management's average investment size is $283.1M across its portfolio of 228 companies.
Recent Wellington Management portfolio additions include Disc Medicine, Tricida, Urban Company, Quince, Span. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors